Article Information
History
- December 18, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Aude Richard*,1,2,†,
- Ania Wisniak*,1,2,
- Javier Perez-Saez2,3,
- Henri Garrison-Desany3,
- Dusan Petrovic1,4,
- Giovanni Piumatti1,5,
- Hélène Baysson1,6,
- Attilio Picazio1,
- Francesco Pennacchio1,
- David De Ridder1,6,
- François Chappuis6,7,
- Nicolas Vuilleumier8,9,
- Nicola Low10,
- Samia Hurst11,
- Isabella Eckerle12,13,
- Antoine Flahault2,6,7,
- Laurent Kaiser9,12,14,
- Andrew S Azman2,3,
- Idris Guessous*,1,6,
- Silvia Stringhini*,1,4,6,
- For the SEROCOV-POP study group
- 1Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
- 2Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- 3Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 4University Centre for General Medicine and Public Health (UNISANTE), University of Lausanne, Lausanne, Switzerland
- 5Faculty of BioMedicine, Università della Svizzera Italiana, Lugano, Switzerland
- 6Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- 7Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland
- 8Division of Laboratory Medicine, Geneva University Hospitals, Geneva, Switzerland
- 9Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- 10Institute of Social and Preventive Medicine, Faculty of Medicine, University of Bern, Bern, Switzerland
- 11Institute for Ethics, History, and the Humanities, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- 12Geneva Center for Emerging Viral Diseases and Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland
- 13Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- 14Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
- ↵† Corresponding author; email: aude.richard{at}unige.ch
↵* these authors contributed equally to this work
Contributors SS, AW, AF, LK, and IG conceived the study. AR, AW, DP, GP, HB, AP, FP and SS contributed to the scientific coordination and data management during the study, AR and AW drafted the first version of the manuscript. JPS, HGD, ASA and SS contributed to drafting sections of the manuscript. JPS, HGD, AW and AP did data analyses. SY, IAV, IE, NV, BM, and LK did lab analyses. GP, HB, ASA, DDR, DPe, FP, MEZ, FC, NL, SH, KMP-B, DT, DPi and LG participated in the study design and helped to draft the manuscript. All authors contributed to the interpretation of data and read and approved the final manuscript.
Posted December 18, 2020.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study
